© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 3, 261-265,
February 2, 2000
© 2000 Oxford University Press
REPORTS |
Twinship and Risk of Postmenopausal Breast Cancer
Affiliations of authors: J. R. Cerhan, J. E. Olson, T. A. Sellers, Department of Health Sciences Research, Mayo Clinic, Rochester, MN; L. H. Kushi, A. R. Folsom, Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis; S. S. Rich, Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; W. Zheng, University of South Carolina School of Public Health, South Carolina Cancer Center, Columbia.
Correspondence to: James R. Cerhan, M.D., Ph.D., Department of Health Sciences Research, Mayo Clinic, 200 First St. SW, Rochester, MN 55905 (e-mail: cerhan.james{at}mayo.edu).
BACKGROUND: Intrauterine exposure to high levels of endogenous estrogens has been hypothesized to increase the risk of breast cancer. Because estrogens and other pregnancy hormones are substantially elevated in twin pregnancies, and possibly more so in dizygotic twin pregnancies, we evaluated the association between aspects of twin membership (i.e., belonging to a twin pair) and the risk of breast cancer. METHODSs: In a cohort of 29 197 postmenopausal Iowa women with no prior diagnosis of cancer (except for nonmelanoma skin cancer), breast cancer risk factors were determined by use of a mailed questionnaire in 1986 (baseline); twin membership, sex of the twin, and zygosity were determined by use of a follow-up questionnaire in 1992. RESULTS: Within the cohort, 1.8% (n = 538) of the women reported being a twin; of these, 24% (n = 130) were monozygotic twins, 63% (n = 337) were dizygotic twins, and 13% (n = 71) did not know their zygosity. From 1986 through 1996, 1230 breast cancers in the cohort were ascertained by linkage to the Iowa Cancer Registry. Compared with singletons, women who belonged to a twin pair were at elevated risk of breast cancer (multivariate-adjusted risk ratio [RR] = 1.72; 95% confidence interval [CI] = 1.22-2.42), with adjustment for educational level, family history of breast cancer, height, body mass index, body fat distribution, age at menarche, age at first live birth, use of hormone replacement therapy, and alcohol use. Multivariate-adjusted risk was elevated (in comparison with singletons) if the sex of the other twin was female (RR = 1.82; 95% CI = 1.20-2.75); however, this risk was limited to female dizygotic twins (RR = 2.14; 95% CI = 1.21-3.79), since no excess risk was evident for monozygotic twins (RR = 1.04; 95% CI = 0.43-2.50). The risk to women with a male twin was also elevated (RR = 1.49; 95% CI = 0.80-2.78) in comparison with singletons, but this estimate was not statistically significant. CONCLUSIONS: This cohort study lends further support to the theory that there are important intrauterine influences on carcinogenesis of the breast.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Troisi, P. Lagiou, D. Trichopoulos, B. Xu, L. Chie, F. Z. Stanczyk, N. Potischman, H.-O. Adami, R. N. Hoover, and C.-C. Hsieh Cord Serum Estrogens, Androgens, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 in Chinese and U.S. Caucasian Neonates Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 224 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Troisi, N. Potischman, and R. N. Hoover Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Neale, G. Mineau, D. C. Whiteman, P. A. Brownbill, and M. F.G. Murphy Childhood and Adult Cancer in Twins: Evidence from the Utah Genealogy Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1236 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Peck, B. S. Hulka, D. A. Savitz, D. Baird, C. Poole, and B. E. Richardson Accuracy of Fetal Growth Indicators as Surrogate Measures of Steroid Hormone Levels during Pregnancy Am. J. Epidemiol., February 1, 2003; 157(3): 258 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Titus-Ernstoff, K. M. Egan, P. A. Newcomb, J. Ding, A. Trentham-Dietz, E. R. Greenberg, J. A. Baron, D. Trichopoulos, and W. C. Willett Early Life Factors in Relation to Breast Cancer Risk in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., February 1, 2002; 11(2): 207 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shibata, D. T. Harris, and P. R. Billings Concentrations of Estrogens and IGFs in Umbilical Cord Blood Plasma: A Comparison among Caucasian, Hispanic, and Asian-American Females J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 810 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kaijser, P. Lichtenstein, F. Granath, G. Erlandsson, S. Cnattingius, and A. Ekbom In Utero Exposures and Breast Cancer: a Study of Opposite-Sexed Twins J Natl Cancer Inst, January 3, 2001; 93(1): 60 - 62. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hilakivi-Clarke Estrogens, BRCA1, and Breast Cancer Cancer Res., September 1, 2000; 60(18): 4993 - 5001. [Abstract] [Full Text]
|
|